Optomed PLC

OPTOMED · Nasdaq Helsinki · Healthcare

1.46EUR −0.7%last day

Price as of 2 October 2026

The price over the past year, with dividends: −59.9%

Performance

1 month

−9.8%

1 year

−59.9%

3 years, per year

−18.9%

5 years, per year

−33.3%

Largest fall, 3 years

−87.4%

Below the peak now

−92.3%

Volatility, 1 year

60.4%

Return with dividends reinvested.

Key figures

P/E

negative earnings

P/B

1.4

Dividend yield

0.0%

Return on equity

−25.1%

Net margin

−33.9%

Market value

34 m USD

Quality, value and trend

Where Optomed stands against every Nordic stock today. 100 is best.

Quality74

Profitability and a sound balance sheet over time. Better than 74% of Nordic stocks.

Value36

The price measured against earnings, assets and cash flow. Better than 36% of Nordic stocks.

Trend7

The price development over the past year. Better than 7% of Nordic stocks.

Combined26

Quality, value and trend together. Better than 26% of Nordic stocks.

About Optomed

Optomed PLC is a company in healthcare, listed on Nasdaq Helsinki. The share trades in EUR. It has around 110 employees.

Optomed Oyj, together with its subsidiaries, manufactures and sells handheld fundus cameras in Finland, rest of Europe, and internationally. The company operates in two segments, Devices and Software. It develops, manufactures, and sells fundus cameras for ophthalmologists, pediatricians, endocrinologists, neurologists, and primary health care professionals; and provides professional IT consulting services for government institutions. The company also provides camera products under the Optomed Smartscope Pro, Optomed Aurora, Optomed Aurora AEYE, Optomed Polaris, and Optomed Lumo brand names, as well as OEM cameras under the Volk Optical, Carl Zeiss Meditec, and Topcon brands.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis